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ABSTRACT 
Electron microscope studies were done on mouse liver, from 5 min to 8 wk after an 
intravenous  injection  of  liposomes  containing  ethylenediaminetetraacetic  acid 
(EDTA). Livers of mice receiving an injection of liposomes containing KCl instead 
of EDTA  or an injection  of a  solution  of EDTA were also examined.  Liposomes 
were  shown  to be phagocytized by hepatocytes as well as by Kupffer cells within 
minutes  after  the  injection.  Initially,  there  was  a  close  contact  between  the 
liposomai membrane and  the  cellular membrane,  followed by an  invagination  of 
the latter and the formation of a distinct vesicle surrounding a single liposome or a 
cluster of several liposomes. No fusion  between the liposomal membrane and the 
cell membrane was observed. Between  15 min and 6 h after liposome injection, the 
Kupffer cells were found to have an increased number of lysosomes and autophagic 
vacuoles.  Within  the  latter,  morphologically  intact  liposomes  or  remnants  of 
liposomes could be seen. At 12 h after injection, a striking increase in macrophages 
was  observed  in  the  liver sinusoids  of EDTA-liposome-injected  mice,  but  not  in 
those  of  KCl-liposome-injected  mice.  Within  the  macrophages,  remnants  of 
liposomes occasionally could be observed. However, the origin and the physiologi- 
cal role of these cells are unknown.  In the hepatocytes, morphological changes were 
first observed 24 h after injection; there were large numbers of autophagic vacuoles, 
and  some  cells  showed  extensive  areas  of  focal  cytoplasmic degeneration.  The 
morphology of the liver cells returned  to normal about 7 days after injection.  No 
morphological changes  were observed in  livers of mice receiving EDTA  solution 
without  liposomes,  A  possible  mechanism  by  which  the  liposome-encapsulated 
chelating agents can successfully remove intracellular toxic metals is discussed. The 
use of liposomes as carriers seems to be a  useful tool for intracellular delivery of 
chelating agents or drugs in  general. 
For  the  last  20  yr,  the  polyaminopolycarboxylic 
acid-chelating  agents,  ethylenediaminetetraacetic 
acid  (EDTA)  and  diethylenetriaminepentaacetic 
acid  (DTPA),  have  been  the  drugs of choice  for 
therapy of poisoning  by various metals. However, 
the  inability  of  these  chelating  agents  to  cross 
cellular  membranes  (1,  3)  seriously  limits  their 
efficacy in  removing the  intracellular  fraction of 
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within  liposomes,  which  are  multilayered  lipid 
spherules  made  of  a  dried  thin  film  of  a  phos- 
pholipid (e.g., lecithin) with or without cholesterol. 
Liposomes  containing  DTPA,  when  injected  into 
mice,  are  readily  taken  up  by  tissue  cells.  These 
liposomes have been  successful in  removing vari- 
ous  intracellularly  deposited  toxic  metals  from 
mice  (e.g.,  plutonium,  lead,  and  inorganic 
mercury)  (7,  8)? 
Morphological studies of cells in various tissues 
after  injection  of liposomes  containing  chelating 
agents  were  undertaken  in  order to  elucidate:  (a) 
the  way  liposomes  are  taken  up  by cells; (b)  the 
mechanism  by  which  the  liposome-transported 
chelating  agent  could  successfully  chelate  and 
remove the intracellularly deposited metals; (c) the 
possible cellular damage induced by the intracellu- 
lar release of chelating agents by liposomes. Lipo- 
somes were found to be readily taken up by cells in 
various tissues. The present paper will describe the 
uptake  of  liposomes  containing  chelating  agents 
into liver cells and the cellular responses at subse- 
quent  time  intervals.  A  possible  mechanism  of 
removal of intracellular metals from liver cells by 
liposome-encapsulated  chelating  agents  is  pre- 
sented. 
MATERIALS  AND  METHODS 
Materials 
Phosphatidylcholine (egg lecithin) was obtained from 
Sigma Chemical Co.,  St.  Louis,  Mo.  Cholesterol was 
acquired  from  Applied Science Labs.,  Inc., State Col- 
lege,  Pa. Uniformly labeled  [t~C]ethylenediaminetetraa- 
cetic acid ([~4C]EDTA),  in the form of the sodium salt 
and at a  specific  activity of 24 mCi per millimole, was 
purchased  from  Amersham/Searle  Corp.,  Arlington, 
Heights,  Iil.  Nonlabeled  EDTA  was  obtained  from 
Fisher Scientific Co., Fair Lawn, N.J. 
Preparation of EDTA-Liposomes 
Liposomes containing EDTA were prepared as previ- 
ously described  (9).  A  mixture  of phosphatidylcholine 
(PC) and cholesterol, at a ratio of 3:1 on a weight basis, 
was  used  throughout  the  present  study.  When  PC  is 
partially oxidized  or contaminated with free fatty acids, 
the  liposomes  obtained  tend  to  aggregate  into  small 
clumps.  Therefore,  PC  of  high  purity  is  required  for 
satisfactory preparation of liposomes. 
1 M. W. Rosenthal, Y.-E. Rahman, E. S. Moretti, and E. 
A. Cerny. Submitted for publication. 
Morphological Identification of 
EDTA-Liposomes in Mouse Liver After an 
Injection of Concentrated Liposomes 
As a pilot experiment to identify liposomes within the 
liver,  each  of two  female  CFI  mice  (Carworth  Div., 
Charles  River  Breeding  Laboratories,  Inc.,  Wilming- 
ton, Mass.), 95 days of age and weighing 28.0 g, received 
a single  injection of 1.0 ml of concentrated EDTA-lipo- 
sprees containing 48  mg of total lipid, via a  tail vein. 
They  were killed  10  rain  after the  injection, and  liver 
samples were taken for electron microscope examination. 
Injection of EDTA-Liposomes for 
Electron Microscope Studies on the 
Cellular Uptake and Subsequent Fate 
of Liposomes 
A  total  of  18  female  CF1  mice  were  used.  Each 
mouse  received  a  single  intravenous  injection  of lipo- 
sprees  containing  about  90,000  cpm  of  [14C]EDTA, 
with a total dose of EDTA at 30mg/kg and in a vol of 
0.4  ml  as  previously  described  (9).  Two  mice  were 
kiUed at each of the following time intervals after the 
liposome injection:  5 rain,  15 min, I h, 6 h, 12 h,  I day, 3 
days. A single mouse was killed at 7 days, 2.5 wk, 4 wk, 
and 8 wk. Samples from the liver were taken for electron 
microscope examination. 
Injection of KCI-Liposomes and 
Nonliposome-encapsulated EDTA for 
Electron Microscope Studies 
Two groups  of six mice each  were  used.  One group 
received  a  single  intravenous  injection  of  liposomes 
containing KCI instead  of EDTA, and the other group a 
single  intravenous  injection  of  EDTA  solution.  The 
amount of lipid in the liposomes, or the dosage of EDTA, 
received by these  mice was the same as that received by 
the EDTA-liposome-treated mice.  A single mouse from 
each group was killed at the following time intervals after 
injection:  15  min,  6  h,  12  h,  24  h,  1 wk,  and  2  wk. 
Samples  from the liver were  taken  for electron  micro- 
scope examination. 
Preparation of Tissues for 
Transmission Electron Microscopy 
Small  pieces  of  tissue  were  fixed  for  4-6  h  in 
phosphate-buffered  paraformaldehyde-glutaraldehyde 
(4) at pH 7.4, washed overnight in phosphate buffer, and 
postfixed in phosphate-buffered I% osmium tetroxide for 
1 h. Some samples were fixed directly in phosphate-buff- 
ered  1%  osmium  tetroxide  for  1  h.  After  osmium 
fixation, the tissues  were  rinsed  with  phosphate  buffer, 
dehydrated  in graded  alcohols, and  infiltrated  and  em- 
bedded  in  Epon  (5). Sections were  cut  with  a  DuPont 
diamond knife (DuPont  Instruments, Wilmington, Del.) 
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uranyl acetate for I h and then lead citrate (12) for 2 rain, 
and  examined  in  a .IEOLCO  JEM-7A electron  micro- 
scope. 
RESULTS 
Liver Morphology of Mice After Receiving 
Nonliposome-encapsulated ED TA 
Between  15 rain and 2 wk after a single intrave- 
nous injection of EDTA solution, the livers of mice 
show no morphological changes. 
Morphological Identification of 
Liposomes Injected into Mice 
The  morphology  of  liposomes  can  be  easily 
demonstrated in the mouse liver after an injection 
of highly concentrated EDTA-liposomes (Fig.  I). 
The liposomes appear as bodies formed of multiple 
bilayers of lipids. The lipid bilayers have a  rather 
dense  appearance under the electron microscope. 
The  irregular shape  of injected liposomes differs 
from  the  usual  spheroid  shape  of liposomes sus- 
pended  in  solution.  10  min  after the  injection of 
such  a  large  amount  of liposomes,  most  of the 
liposomes  are  still  seen  in  the  liver  sinusoids. 
However,  some  are  within  the  space  of  Disse 
among the microvilli of the hepatocyte (Fig. 21 and 
some are more deeply lodged within the infoldings 
of the cellular membrane (Figs. 3, 4). 
Uptake of Liposomes by Liver Cells 
and Their Subsequent Fate 
Liposomes  appear  in  both  hepatocytes  and 
Kupffer  cells  within  a  short  time  after  either 
EDTA-liposome or KCl-liposome injection. Figs. 
5 and 6 show EDTA-liposomes within liver paren- 
chymal cells 15 min after injection, In both figures 
the liposome is located near the sinusoidal margin 
of the cell. Liposomes are also seen at this time in 
the Kupffer cells lining the liver sinusoid (Figs. 7, 
8).  More than  one liposome are usually found in 
the  cytoplasm  of the  Kupffer  cells.  These  lipo- 
somes  are  clustered  together  in  large  vacuolar 
areas. 
The  liver  shows  no  significant  morphological 
changes from  15 min to 6 h after injection, except 
for a decrease in the number of liposomes found in 
the sinusoids and a concomitant increase in num- 
ber of liposomes in both hepatocytes and Kupffer 
cells.  12  h  after  EDTA-liposome injection, how- 
ever,  numerous  macrophages  appear  filling  the 
sinusoids  (Figs.  9,  10).  The  cytoplasm  of these 
macrophages contains  numerous  granules.  How- 
ever, no such mobilization of macrophages can be 
observed  in  the  liver sinusoids of mice  receiving 
KCl-liposomes (Fig.  11),  even  though  liposome- 
like  vesicles can  be  found  in  Kupffer  cells  and 
hepatocytes of these  livers (Figs.  11,  12).  In  the 
livers of EDTA-liposome-injected mice, engorged 
Kupffer cells exhibiting the same kind of vacuolar 
areas  containing  liposomes  as  found  at  earlier 
times bulge into the sinusoidal lumen. At 12 h, the 
Kupffer cell cytoplasm also shows an  increase in 
lysosomes  and  residual  bodies.  The  hepatocytes 
show no differences in structure from earlier times. 
The  liver examined  24  h  after injection of the 
mice with  EDTA-liposomes shows the  first mor- 
phological change  in  the  hepatocytes. There  are 
large  patches  of  autophagic  vacuoles  with  in- 
creased  numbers  of  lysosome-like dense  bodies 
(Fig.  13). Liposomes can still be identified within 
these  areas  of  degeneration.  Single  liposomes 
within  a  vacuolar enclosure are still found  in  the 
hepatocytes, but are closer to the region of the bile 
canaliculus and lysosomes (for example, the single 
liposome within  a  vacuole  seen  in  Fig.  14). The 
Kupffer cells are the same as at earlier times. Their 
cytoplasm contains liposomes in  association with 
autophagic  vacuoles  (Figs.  15,  16).  No  striking 
morphological changes are seen in hepatocytes of 
mice receiving KCl-liposomes 24  h earlier. How- 
ever,  vacuoles  with  liposome-like inclusions can 
still be observed in some of the Kupffer cells. 
The  liver has  returned  to  a  relatively normal 
appearance  at  1  wk  after  injection  of  EDTA- 
liposomes (Fig.  17). However, some Kupffer cells 
still exhibit large vacuolar areas and a concentra- 
tion  of liposomal remnants (Fig.  18). By  2.5  wk, 
the  liver  morphology  appears  entirely  normal 
(Figs.  19, 20). 
DISCUSSION 
We  have  demonstrated  by  electron  microscope 
studies  that  liposomes  containing  the  chelating 
agent EDTA rapidly enter liver cells by pbagocyto- 
sis. The  penetration  of liposomes into tissue cells 
within minutes after the liposome injection is also 
supported by our previous kinetic studies showing 
their rapid disappearance from the blood (91. We 
have reported also that mice receiving [~'C]EDTA 
encapsulated within liposomes show a higher con- 
centration and longer retention of the ~'C-radioac- 
114  TrtF JOURNAL OF CELL BIOLOGY  ,  VOLUME 65,  1975 FIGURE  1  Liposomes (L) can be identified in the sinusoid of the liver within  10 min after an injection of 
1.0  ml of packed  EDTA-liposomes. Length of bar equals  I vm  in  all  figures unless otherwise stated,  x 
12,000. 
FIGURE  2  The liver sinusoid is occupied by an erythrocyte and a  liposome (L center). Smaller, flattened 
liposomes (L) can be identified among the microvilli within the space of Disse.  ￿  I0,000. 
FIGURES  3  and  4  Higher magnifications of the margin of the hepatocyte show a liposome (L) within an 
invagination of the hepatic cellular membrane.  ￿  36,000, FIGURES  5  and  6  Liposomes (L) are shown in the cytoplasm of the hepatocyte within a vacuolar space 
near the sinusoidal margin 15 rain after injection of EDTA-liposomes. Fig. 5, ￿  32,000. Fig. 6, ￿  19,000. 
FIGUgES  7  and  8  15 rain after injection of EDTA-liposomes (L), the Kupffer cell cytoplasm is filled with 
large vacuolar areas which contain liposomes. The  Kupffer cell seems engorged and occupies almost the 
entire sinusoid. Fig. 7,  ￿  8,200.  Fig. 8,  ￿  12,500. FIGURES  9  and  10  12 h after injection of EDTA-liposomes, the sinusoid is filled with macrophages and 
engorged Kupffer cells.  The montage (Fig. 9/shows a macrophage filled  with dense granules. Most of the 
figure is occupied by a Kupffer cell with large vacuolar areas containing liposomes. The sinusoid (Fig.  10) 
contains parts of four macrophages. Fig. 9,  x  I 1,000. Fig.  10,  x  9,000. 
i17 FIGURES  I 1  and  12  12 h after injection of KCl-liposomes, a large portion of the sinusoid is occupied by a 
Kupffer cell, within which vacuolar areas containing liposome-like remnants are seen (Fig.  l 1).  A  single 
liposome surrounded by vacuolar space is seen in the hepatocyte (Fig.  12). No macrophages are observed in 
the sinusoids (Figs.  II  and  12).  Figs.  II  and  12,  ￿  10,750. 
118 FIGURES  13,  14,  15,  and  16  24 h  after  injection of EDTA-liposomes,  the liver shows several morpho- 
logical  changes.  The  hepatocytes  have  large  areas  of cytoplasmic  degeneration  containing  remnants  of 
liposomes  (Fig.  13).  Single  liposomes  enclosed  in  a  vacuolar  area  are  found  in  the  region  of the  bile 
canaliculus (Fig.  14). The Kupffer cell cytoplasm contains large autophagic vacuoles and liposomes in close 
association  with these vacuoles (Figs.  15 and  16).  Figs.  13 and  14,  x  12,500.  Fig.  15,  x  9,000.  Fig.  16,  x 
12,500. FIGURES  17  and  18  1 wk  after  injection  of EDTA-liposomes, the  liver  parenchymal cell  returns to  a 
normal appearance (Fig.  17).  The  Kopffer cell  still  has areas with  large autophatic  vacuoles containing 
remnants of liposomes (Fig.  18).  Fig.  17,  x  12,500.  Fig.  19,  x  10,500. 
FIGURES  19  and  20  At  2.5  wk  postinjection,  the  liver  exhibits  an  entirely  normal  morphology.  The 
hepatocytes show no areas of degeneration, and no liposomes or their remnants are found. The lumen of the 
sinusoid contains no free liposomes, the macrophages have disappeared, and the Kupffer cells have returned 
to normal and are no longer engorged. Fig.  19,  ￿  5,000.  Fig. 20,  x  6,250. tivity  in  various  tissues  than  do  mice  receiving 
nonencapsulated [t4C]EDTA solution (9). By com- 
bining results of the kinetic studies and the present 
morphological studies, we can reasonably assume 
that the chelating agent encapsulated within lipo- 
somes has been successfully transported across the 
cellular membrane. 
The  injection into  mice of the  chelating agent 
DTPA  in  liposome-encapsulated  form  has  been 
shown to remove a fraction of the metal plutonium 
from the liver that was not available to nonencap- 
sulated  DTPA  therapy  (8). 1 This  fraction  of the 
metal is presumably localized inside the liver cells. 
Thus,  chelating  agents  injected  in  encapsulated 
form were not only transported across the cellular 
membrane,  but  they were  released inside the cell 
where  they  successfully  chelated  the  metal  and 
removed it from the cells. 
We  have  demonstrated  here  that  liposomes 
containing chelating agents are rapidly taken up by 
both  Kupffer and  parenchymal cells of the  liver, 
but  we  have  not  attempted  to  determine  the 
number of liposomes in the two cell types. We plan 
to  approach  this  problem  by  using  radioactively 
labeled liposomes and subsequent cellular fraction- 
ation of the liver to separate the hepatocytes from 
Kupffer cells. 
As phosphatidylcholine and cholesterol are both 
normal constituents of all cellular and intracellular 
membranes,  the  determination of the  fate  of the 
injected  liposomes  within  the  cells  is  a  most 
difficult problem. We have labeled liposomes with 
[~'C]cholesterol and  attempted to  use autoradio- 
graphic  techniques  to  study  their  metabolism 
within cells. This approach was unproductive, due 
to the extremely rapid exchange of the [l~C]choles- 
terol  incorporated  in  the  liposomal lipid bilayer 
with  the  cholesterol  of intracellular membranes. 
About 30% of the liposomal l~C-radioactivity was 
found outside the labeled liposomes as early as 15 
min after the liposome injection. In vitro exchange 
of  cholesterol  and  phospholipids  between  lipo- 
somes and intracellular particles such as mitochon- 
dria has also been reported recently (2). 
Our previous studies showed that about 40%  of 
liposome-encapsulated [~C]EDTA  was  taken  up 
by the liver, and remained in the liver up to  12 h 
before a significant decrease could be observed (9). 
This long  retention  of [I~C]EDTA  in  the  liver is 
probably due to the slow  release of the chelating 
agent  from  within  the  liposomes.  This  retention 
and  slow  release  would  provide  the  cells with  a 
continuous  high  intracellular  level  of  chelating 
agent compared to the levels after injection of the 
nonencapsulated EDTA (9). Therefore, the chelat- 
ing  capacity  of  liposome-encapsulated chelating 
agents for the intracellular metal deposits is mark- 
edly improved. 
After administration  of liposome-encapsulated 
DTPA  to  mice  injected with  plutonium,  the  uri- 
nary  excretion  of  plutonium  is  significantly in- 
creased  over  that  of mice  receiving the  conven- 
tional,  nonencapsulated  DTPA  therapy,  while 
there  is  no  difference  in  the  fecal  excretion  of 
plutonium  after  the  two  forms  of  therapy  (8). 
The  increased  plutonium  excretion  through  the 
urine  rather  than  the  feces could  be due  to  the 
high level of DTPA  maintained over a  prolonged 
period  within  the  liver  cells  by  the  liposomes. 
This  maintained level was  sufficient to break  up 
the  large  molecules of polymeric plutonium  into 
smaller  particles,  capable  of  crossing  the  cell 
membrane  into  the  liver  sinusoids,  and  thereby 
gaining access to  the  kidneys.  Future  studies on 
the  molecular form  of plutonium  chelates in  the 
urine  will be  necessary to  confirm  such  a  possi- 
bility. 
The  origin  of the  numerous  macrophages that 
appeared  in  the  liver sinusoids of mice receiving 
[14C]EDTA liposomes is not known. These macro- 
phages appear rather specifically at  12 h after the 
liposome injection, and  are not observed in  mice 
receiving KCl-liposomes. For this rather puzzling 
phenomenon,  we would like to offer the following 
hypothesis:  after  the  injection  of liposomes con- 
taining chelating agents, soluble metal chelates are 
released from  liver cells into the sinusoids. These 
metal chelates may induce either a mobilization of 
macrophages from  other tissues to the liver sinu- 
soids or a  transformation  of the  abundant  endo- 
thelial cells of the  liver sinusoids into  cells with 
macrophage  appearance.  The  macrophages  ob- 
served  at  12  h  after  the  liposomal  [t4C]EDTA 
injection might play a crucial role in the reduction 
of [~4C]EDTA levels in the liver which began  12 h 
after the liposome injection (9). 
In the livers of mice receiving nonencapsulated 
EDTA  solutions, no morphological changes were 
observed.  Vacuole  formation  in  kidney  of  rats 
receiving  injections  of  EDTA  solution  has  been 
reported  by  Schwartz  and  co-workers  (10,  I1). 
They suggested that  EDTA-induced vacuologene- 
sis is an indication of the induction of pinocytosis 
by the chelate. However, the toxic doses of EDTA 
used in their studies (1.0 and 2.5 g EDTA per kg) 
may  have  been  responsible for the  formation  of 
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EDTA,  they  demonstrated  less  than  0.1%  of the 
total  injected  radioactivity  in  cells  of the  kidney 
cortex (1 !).  Low levels of EDTA in kidneys have 
also been shown in our work (9). Only at early time 
intervals after injections, correlated with the early 
and  rapid  EDTA  urinary  excretion  (9),  are  high 
concentrations  of  EDTA  found  in  kidneys.  The 
tissue  disposition  of  liposome-encapsulated 
EDTA,  however,  is strikingly different  from that 
of nonencapsulated  EDTA (9).  The highest thera- 
peutic doses of chelating agents used in our studies 
(7, 8) 1 were 100 mg (EDTA or DTPA) per kg, and 
under  such  experimental  conditions  no  vacuolo- 
genesis was observed in liver, lungs, and spleen, the 
tissues we have examined so far. 
While this paper was in preparation,  a  study on 
the  interaction  of  cationic  liposomes  containing 
horseradish  peroxidase  with  cells  in  culture  was 
reported  by  Magee et  al.  (6).  They  reported  that 
"liposomes  containing  horseradish  peroxidase 
were adsorbed  by HeLa cells at least 300 times as 
effectively  as  was  free  horseradish  peroxidase". 
However, the way by which liposomes were taken 
up  by  HeLa cells was not shown  in their electron 
micrographs.  The  authors  concluded  that  "many 
particles did  not gain  access to the interior of the 
cells, many were phagocytized,  and  some enzyme 
was transferred to the cell membrane, perhaps as a 
result  of fusion  of the  liposomal  membrane  with 
the  cell  membrane."  In  our  present  study,  lipo- 
somes were taken up into cells by way of phagocy- 
tosis,  and  no  fusion  of the  liposomal  membrane 
with  the  cell membrane  was  observed.  Fusion  of 
liposomal  membrane  with  cell  membranes  can 
be  detected  by  electron  microscopy,  where  con- 
tact  between  the  two  membranes  can  be  ob- 
served,  and  no  space  should  be  found  between 
these two membranes. 
In conclusion,  we have demonstrated  that  lipo- 
somes  containing  the  chelating  agent  EDTA  are 
phagocytized by liver cells within minutes of their 
injection.  Both parenchymal and  Kupffer cells are 
capable  of  taking  up  liposomes.  The  chelating 
agents  introduced  into  liver cells could  therefore 
explain  the  higher  efficiency  of  liposome-encap- 
sulated chelating agent compared to the nonencap- 
sulated  form in removing intracellular heavy met- 
als.  Thus  the  use  of  liposomes  as  carriers  to 
introduce  chelating  agents  (or  other  drugs)  into 
cells  seems  to  be  a  useful  tool  for  intracellular 
delivery of drugs. The lipid spherules also have the 
advantage  of  being  completely  "biodegradable" 
and in addition,  as they are not protein in nature, 
immunological reactions are unlikely to occur. 
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